Learn More
Medchemexpress LLC Pasireotide acetate | 396091-76-2 | 99.5% | 1107.26 | 1 MG

Supplier: Medchemexpress LLC HY16381A1MG
Pasireotide acetate is a long-acting cyclohexapeptide somatostatin analogue. It enhances agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5). This compound can suppress Growth Hormone (GH), Insulin-like Growth Factor-I (IGF-I), and Adrenocorticotropic Hormone (ACTH) secretion, indicating potential effectiveness in treating acromegaly and Cushing's disease.
- Enhances agonist activity at somatostatin receptors
- Suppresses GH, IGF-I, and ACTH secretion
- Exhibits antisecretory, antiproliferative, and proapoptotic activities
- Effectively inhibits GHRH-induced GH release in primary rat pituitary cells
- Decreases serum insulin and increases serum glucose in vivo
- Reduces tumor size and increases apoptosis in Pdx1-Cre mice
- Exerts antinociceptive and antiinflammatory actions via SSTR2 receptor
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.